* We recommend a score >= 0.08 for meaningful Gene-Disease associations
GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | ![]() | DisGeNet_sourceDB |
5594 | MAPK1 | C0027627 | Neoplasm Metastasis | 0.220011989115605 | BEFREE;CTD_human;LHGDN |
5594 | MAPK1 | C0007137 | Squamous cell carcinoma | 0.217236010518839 | BEFREE;CTD_human;LHGDN |
5594 | MAPK1 | C0919267 | ovarian neoplasm | 0.208473464178654 | BEFREE;CTD_human;LHGDN |
5594 | MAPK1 | C0038356 | Stomach Neoplasms | 0.208198737394441 | CTD_human;LHGDN |
5594 | MAPK1 | C0024121 | Lung Neoplasms | 0.206290005282267 | BEFREE;CTD_human;LHGDN |
5594 | MAPK1 | C0005586 | Bipolar Disorder | 0.200824180352639 | BEFREE;PSYGENET |
5594 | MAPK1 | C0022665 | Kidney Neoplasm | 0.200549453568426 | BEFREE;CTD_human |
5594 | MAPK1 | C0036341 | Schizophrenia | 0.200274726784213 | BEFREE;PSYGENET |
5594 | MAPK1 | C0243026 | Sepsis | 0.200274726784213 | BEFREE;CTD_human |
5594 | MAPK1 | C0878544 | Cardiomyopathies | 0.200274726784213 | BEFREE;CTD_human |
5594 | MAPK1 | C0151526 | Premature Birth | 0.2 | HPO |
5594 | MAPK1 | C0155862 | Streptococcal pneumonia | 0.2 | CTD_human |
5594 | MAPK1 | C0178417 | Anhedonia | 0.2 | PSYGENET |
5594 | MAPK1 | C0233315 | Premature birth of newborn | 0.2 | HPO |
5594 | MAPK1 | C0236736 | Cocaine-Related Disorders | 0.2 | CTD_human |
5594 | MAPK1 | C0264133 | Acquired flat foot | 0.2 | HPO |
5594 | MAPK1 | C0349588 | Short stature | 0.2 | HPO |
5594 | MAPK1 | C0423224 | Sunken eyes | 0.2 | HPO |
5594 | MAPK1 | C0423903 | Low intelligence | 0.2 | HPO |
5594 | MAPK1 | C0424688 | Small head | 0.2 | HPO |
5594 | MAPK1 | C0557874 | Global developmental delay | 0.2 | HPO |
5594 | MAPK1 | C0917816 | Mental deficiency | 0.2 | HPO |
5594 | MAPK1 | C1142533 | Smooth philtrum | 0.2 | HPO |
5594 | MAPK1 | C1386048 | Intrauterine retardation | 0.2 | HPO |
5594 | MAPK1 | C1834055 | Thin hypoplastic alae nasi | 0.2 | HPO |
5594 | MAPK1 | C1843367 | Poor school performance | 0.2 | HPO |
5594 | MAPK1 | C1844505 | Pointed chin | 0.2 | HPO |
5594 | MAPK1 | C1844554 | Absent fingernails | 0.2 | HPO |
5594 | MAPK1 | C1844555 | Absent toenails (anonychia) | 0.2 | HPO |
5594 | MAPK1 | C1850049 | Bilateral fifth finger clinodactyly | 0.2 | HPO |
5594 | MAPK1 | C1864897 | Cognitive delay | 0.2 | HPO |
5594 | MAPK1 | C1865017 | Thin upper lip vermilion | 0.2 | HPO |
5594 | MAPK1 | C1866282 | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | 0.2 | CTD_human |
5594 | MAPK1 | C1868571 | Thick, flared eyebrows | 0.2 | HPO |
5594 | MAPK1 | C2678480 | Chromosome 22q11.2 Deletion Syndrome, Distal | 0.2 | ORPHANET |
5594 | MAPK1 | C0007786 | Brain Ischemia | 0.2 | CTD_human |
5594 | MAPK1 | C0014306 | Enophthalmos | 0.2 | HPO |
5594 | MAPK1 | C0015934 | Fetal Growth Retardation | 0.2 | HPO |
5594 | MAPK1 | C0016202 | Flatfoot | 0.2 | HPO |
5594 | MAPK1 | C0017639 | Gliosis | 0.2 | CTD_human |
5594 | MAPK1 | C0018671 | Head and Neck Neoplasms | 0.2 | CTD_human |
5594 | MAPK1 | C0020429 | Hyperalgesia | 0.2 | CTD_human |
5594 | MAPK1 | C0020564 | Hypertrophy | 0.2 | CTD_human |
5594 | MAPK1 | C0021296 | Infant, Small for Gestational Age | 0.2 | HPO |
5594 | MAPK1 | C0021361 | Female infertility | 0.2 | CTD_human |
5594 | MAPK1 | C0023015 | Language Disorders | 0.2 | HPO |
5594 | MAPK1 | C0025362 | Mental Retardation | 0.2 | HPO |
5594 | MAPK1 | C0027626 | Neoplasm Invasiveness | 0.2 | CTD_human |
5594 | MAPK1 | C0027746 | Nerve Degeneration | 0.2 | CTD_human |
5594 | MAPK1 | C0036920 | Sezary Syndrome | 0.2 | CTD_human |
5594 | MAPK1 | C0038587 | Substance Withdrawal Syndrome | 0.2 | CTD_human |
5594 | MAPK1 | C0040997 | Trigeminal Neuralgia | 0.2 | CTD_human |
5594 | MAPK1 | C3495559 | Juvenile arthritis | 0.2 | CTD_human |
5594 | MAPK1 | C4280538 | Curvature of little finger | 0.2 | HPO |
5594 | MAPK1 | C4021808 | Abnormality of earlobe | 0.2 | HPO |
5594 | MAPK1 | C4020876 | Dull intelligence | 0.2 | HPO |
5594 | MAPK1 | C4020875 | Mental and motor retardation | 0.2 | HPO |
5594 | MAPK1 | C4020867 | Persistant truncus arteriosus | 0.2 | HPO |
5594 | MAPK1 | C4020849 | Bowed and upward slanting eyebrows | 0.2 | HPO |
5594 | MAPK1 | C3714756 | Intellectual Disability | 0.2 | HPO |
5594 | MAPK1 | C0004352 | Autistic Disorder | 0.0805494535684262 | BEFREE;MGD |
5594 | MAPK1 | C0011853 | Diabetes Mellitus, Experimental | 0.08 | RGD |
5594 | MAPK1 | C0026766 | Multiple Organ Failure | 0.08 | RGD |
5594 | MAPK1 | C0036982 | Shock, Hemorrhagic | 0.08 | RGD |
5594 | MAPK1 | C0041972 | Urethral Obstruction | 0.08 | RGD |
5594 | MAPK1 | C0042024 | Urinary Incontinence | 0.08 | RGD |
5594 | MAPK1 | C0220704 | Shprintzen syndrome | 0.08 | MGD |
5594 | MAPK1 | C0025202 | melanoma | 0.0287888908331065 | BEFREE;LHGDN |
5594 | MAPK1 | C1458155 | Mammary Neoplasms | 0.0226874800711493 | BEFREE;LHGDN |
5594 | MAPK1 | C0006142 | Malignant neoplasm of breast | 0.0177917284392216 | BEFREE;GAD |
5594 | MAPK1 | C0678222 | Breast Carcinoma | 0.0162088802685729 | BEFREE |
5594 | MAPK1 | C0033578 | Prostatic Neoplasms | 0.0139392891082819 | BEFREE;LHGDN |
5594 | MAPK1 | C0009375 | Colonic Neoplasms | 0.0136645623240688 | LHGDN |
5594 | MAPK1 | C3714514 | Infection | 0.0136645623240688 | LHGDN |
5594 | MAPK1 | C2239176 | Liver carcinoma | 0.0112637981527371 | BEFREE |
5594 | MAPK1 | C0001418 | Adenocarcinoma | 0.00984709809971986 | BEFREE;LHGDN |
5594 | MAPK1 | C0017638 | Glioma | 0.00960108207014125 | BEFREE;LHGDN |
5594 | MAPK1 | C0596263 | Carcinogenesis | 0.0090659838790323 | BEFREE |
5594 | MAPK1 | C0600139 | Prostate carcinoma | 0.0090659838790323 | BEFREE |
5594 | MAPK1 | C0376358 | Malignant neoplasm of prostate | 0.008241803526393 | BEFREE |
5594 | MAPK1 | C0023418 | leukemia | 0.0079383659875454 | BEFREE;LHGDN |
5594 | MAPK1 | C0009402 | Colorectal Carcinoma | 0.0076923499579668 | BEFREE |
5594 | MAPK1 | C1527249 | Colorectal Cancer | 0.0076923499579668 | BEFREE |
5594 | MAPK1 | C0017636 | Glioblastoma | 0.00767799458064955 | BEFREE;LHGDN |
5594 | MAPK1 | C0026764 | Multiple Myeloma | 0.00767799458064955 | BEFREE;LHGDN |
5594 | MAPK1 | C0002395 | Alzheimer's Disease | 0.00630436065958405 | BEFREE;LHGDN |
5594 | MAPK1 | C3463824 | MYELODYSPLASTIC SYNDROME | 0.0062900052822668 | BEFREE;LHGDN |
5594 | MAPK1 | C0699791 | Stomach Carcinoma | 0.0060439892526882 | BEFREE |
5594 | MAPK1 | C0009404 | Colorectal Neoplasms | 0.0060152784980537 | BEFREE;LHGDN |
5594 | MAPK1 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0057692624684751 | BEFREE |
5594 | MAPK1 | C0024623 | Malignant neoplasm of stomach | 0.0057692624684751 | BEFREE |
5594 | MAPK1 | C1140680 | Malignant neoplasm of ovary | 0.0057037499338452 | BEFREE;GAD |
5594 | MAPK1 | C0235974 | Pancreatic carcinoma | 0.005494535684262 | BEFREE |
5594 | MAPK1 | C0003130 | Anoxia | 0.0054658249296275 | LHGDN |
5594 | MAPK1 | C0346647 | Malignant neoplasm of pancreas | 0.0052198089000489 | BEFREE |
5594 | MAPK1 | C0024299 | Lymphoma | 0.00520545352273165 | BEFREE;LHGDN |
5594 | MAPK1 | C0003873 | Rheumatoid Arthritis | 0.0049450821158358 | BEFREE |
5594 | MAPK1 | C0029925 | Ovarian Carcinoma | 0.0046703553316227 | BEFREE |
5594 | MAPK1 | C0029463 | Osteosarcoma | 0.00465599995430545 | BEFREE;LHGDN |
5594 | MAPK1 | C0027819 | Neuroblastoma | 0.0043956285474096 | BEFREE |
5594 | MAPK1 | C0014175 | Endometriosis | 0.00438127317009235 | BEFREE;LHGDN |
5594 | MAPK1 | C0206698 | Cholangiocarcinoma | 0.00438127317009235 | BEFREE;LHGDN |
5594 | MAPK1 | C0699790 | Colon Carcinoma | 0.0041209017631965 | BEFREE |
5594 | MAPK1 | C0700095 | Central neuroblastoma | 0.0041209017631965 | BEFREE |
5594 | MAPK1 | C0020456 | Hyperglycemia | 0.00410654638587925 | BEFREE;LHGDN |
5594 | MAPK1 | C0019196 | Hepatitis C | 0.00383181960166615 | BEFREE;LHGDN |
5594 | MAPK1 | C0025149 | Medulloblastoma | 0.00383181960166615 | BEFREE;LHGDN |
5594 | MAPK1 | C0030297 | Pancreatic Neoplasm | 0.00383181960166615 | BEFREE;LHGDN |
5594 | MAPK1 | C0036421 | Systemic Scleroderma | 0.00383181960166615 | BEFREE;LHGDN |
5594 | MAPK1 | C0019693 | HIV Infections | 0.0037806624443535 | BEFREE;GAD |
5594 | MAPK1 | C0007102 | Malignant tumor of colon | 0.0035714481947703 | BEFREE |
5594 | MAPK1 | C0033860 | Psoriasis | 0.00355709281745305 | BEFREE;LHGDN |
5594 | MAPK1 | C0023434 | Chronic Lymphocytic Leukemia | 0.0032967214105572 | BEFREE |
5594 | MAPK1 | C0024141 | Lupus Erythematosus, Systemic | 0.0032967214105572 | BEFREE |
5594 | MAPK1 | C0042214 | Vaccinia | 0.00328236603323995 | BEFREE;LHGDN |
5594 | MAPK1 | C0023903 | Liver neoplasms | 0.0030219946263441 | BEFREE |
5594 | MAPK1 | C0332996 | Persistent embryonic structure | 0.0030219946263441 | BEFREE |
5594 | MAPK1 | C0549473 | Thyroid carcinoma | 0.0030219946263441 | BEFREE |
5594 | MAPK1 | C0206694 | Mucoepidermoid Carcinoma | 0.00300763924902685 | BEFREE;LHGDN |
5594 | MAPK1 | C0010606 | Adenoid Cystic Carcinoma | 0.00300763924902685 | BEFREE;LHGDN |
5594 | MAPK1 | C0014859 | Esophageal Neoplasms | 0.00300763924902685 | BEFREE;LHGDN |
5594 | MAPK1 | C0004096 | Asthma | 0.002747267842131 | BEFREE |
5594 | MAPK1 | C0023473 | Myeloid Leukemia, Chronic | 0.002747267842131 | BEFREE |
5594 | MAPK1 | C0178874 | Tumor Progression | 0.002747267842131 | BEFREE |
5594 | MAPK1 | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.00273291246481375 | LHGDN |
5594 | MAPK1 | C0006079 | Bowen's Disease | 0.00273291246481375 | LHGDN |
5594 | MAPK1 | C0008373 | Cholesteatoma | 0.00273291246481375 | LHGDN |
5594 | MAPK1 | C0016059 | Fibrosis | 0.00273291246481375 | LHGDN |
5594 | MAPK1 | C0018800 | Cardiomegaly | 0.00273291246481375 | LHGDN |
5594 | MAPK1 | C0022602 | Actinic keratosis | 0.00273291246481375 | LHGDN |
5594 | MAPK1 | C0029456 | Osteoporosis | 0.00273291246481375 | LHGDN |
5594 | MAPK1 | C0030186 | Paget Disease Extramammary | 0.00273291246481375 | LHGDN |
5594 | MAPK1 | C0023467 | Leukemia, Myelocytic, Acute | 0.0024725410579179 | BEFREE |
5594 | MAPK1 | C0028326 | Noonan Syndrome | 0.0024725410579179 | BEFREE |
5594 | MAPK1 | C0041409 | Turner Syndrome, Male | 0.0024725410579179 | BEFREE |
5594 | MAPK1 | C0027404 | Narcolepsy | 0.002407028523288 | GAD |
5594 | MAPK1 | C0007115 | Malignant neoplasm of thyroid | 0.0021978142737048 | BEFREE |
5594 | MAPK1 | C0028754 | Obesity | 0.0021978142737048 | BEFREE |
5594 | MAPK1 | C0042769 | Virus Diseases | 0.0021978142737048 | BEFREE |
5594 | MAPK1 | C0684249 | Carcinoma of lung | 0.0021978142737048 | BEFREE |
5594 | MAPK1 | C1335302 | Pancreatic Ductal Adenocarcinoma | 0.0021978142737048 | BEFREE |
5594 | MAPK1 | C0585442 | Osteosarcoma of bone | 0.0019230874894917 | BEFREE |
5594 | MAPK1 | C3539878 | Triple Negative Breast Neoplasms | 0.0019230874894917 | BEFREE |
5594 | MAPK1 | C0029408 | Degenerative polyarthritis | 0.0019230874894917 | BEFREE |
5594 | MAPK1 | C0035412 | Rhabdomyosarcoma | 0.0019230874894917 | BEFREE |
5594 | MAPK1 | C0238463 | Papillary thyroid carcinoma | 0.0016483607052786 | BEFREE |
5594 | MAPK1 | C0242379 | Malignant neoplasm of lung | 0.0016483607052786 | BEFREE |
5594 | MAPK1 | C1306460 | Primary malignant neoplasm of lung | 0.0016483607052786 | BEFREE |
5594 | MAPK1 | C2931822 | Nasopharyngeal carcinoma | 0.0016483607052786 | BEFREE |
5594 | MAPK1 | C0152013 | Adenocarcinoma of lung (disorder) | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0409974 | Lupus Erythematosus | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0424295 | Hyperactive behavior | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0677886 | Epithelial ovarian cancer | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0003864 | Arthritis | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0004114 | Astrocytoma | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0007134 | Renal Cell Carcinoma | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0008479 | Chondrosarcoma | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0024131 | Lupus Vulgaris | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0024138 | Lupus Erythematosus, Discoid | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0030567 | Parkinson Disease | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0032019 | Pituitary Neoplasms | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0041296 | Tuberculosis | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C3887505 | DYSFUNCTION - SKIN DISORDERS | 0.0013736339210655 | BEFREE |
5594 | MAPK1 | C0206656 | Rhabdomyosarcoma, Embryonal | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0238462 | Medullary carcinoma of thyroid | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0345904 | Malignant neoplasm of liver | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0375023 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0476089 | Endometrial Carcinoma | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C1868682 | Paroxysmal kinesigenic choreoathetosis | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0003850 | Arteriosclerosis | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0004153 | Atherosclerosis | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0009319 | Colitis | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0011644 | Scleroderma | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0014070 | Encephalomyelitis | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0021400 | Influenza | 0.0010989071368524 | BEFREE |
5594 | MAPK1 | C0002793 | Anaplasia | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0004135 | Ataxia Telangiectasia | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0004364 | Autoimmune Diseases | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0009324 | Ulcerative Colitis | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0010346 | Crohn Disease | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0010674 | Cystic Fibrosis | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0011581 | Depressive disorder | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0025500 | Mesothelioma | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0026769 | Multiple Sclerosis | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0035335 | Retinoblastoma | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C3854222 | Human immunodeficiency virus (HIV) II infection category B1 | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0149925 | Small cell carcinoma of lung | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0175697 | Van der Woude syndrome | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0220633 | Uveal melanoma | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0279626 | Squamous cell carcinoma of esophagus | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0281361 | Adenocarcinoma of pancreas | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0555198 | Malignant Glioma | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0598766 | Leukemogenesis | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C1269683 | Major Depressive Disorder | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C1378703 | Renal carcinoma | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C1519670 | Tumor Angiogenesis | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C1621958 | Glioblastoma Multiforme | 0.0008241803526393 | BEFREE |
5594 | MAPK1 | C0153452 | Malignant neoplasm of gallbladder | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0153676 | Secondary malignant neoplasm of lung | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0153690 | Secondary malignant neoplasm of bone | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0206664 | Teratocarcinoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0206754 | Neuroendocrine Tumors | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0233794 | Memory impairment | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0235782 | Gallbladder Carcinoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0278883 | Metastatic melanoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0279628 | Adenocarcinoma Of Esophagus | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0334583 | Pilocytic Astrocytoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0338106 | Adenocarcinoma of colon | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0345967 | Malignant mesothelioma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0374997 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0398738 | Leukocyte adhesion deficiency type 1 | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0399440 | Hereditary gingival fibromatosis | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0546837 | Malignant neoplasm of esophagus | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0598935 | Tumor Initiation | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0686619 | Secondary malignant neoplasm of lymph node | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0740457 | Malignant neoplasm of kidney | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0812413 | Malignant Pleural Mesothelioma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0948380 | Colorectal cancer metastatic | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C1168401 | Squamous cell carcinoma of the head and neck | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C1261473 | Sarcoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C1290375 | Mesothelioma (malignant, clinical disorder) (disorder) | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C1290884 | Inflammatory disorder | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C1332460 | Barrett's Adenocarcinoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C1510472 | Drug Dependence | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C1883486 | Uterine Corpus Cancer | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C2348820 | Triple-Negative Breast Carcinoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0002726 | Amyloidosis | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0006413 | Burkitt Lymphoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0007103 | Malignant neoplasm of endometrium | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0007114 | Malignant neoplasm of skin | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0010823 | Cytomegalovirus Infections | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0011570 | Mental Depression | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0016057 | Fibrosarcoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0018801 | Heart failure | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0018802 | Congestive heart failure | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0020179 | Huntington Disease | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0021390 | Inflammatory Bowel Diseases | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0022408 | Arthropathy | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0023443 | Hairy Cell Leukemia | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0023470 | Myeloid Leukemia | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0024305 | Lymphoma, Non-Hodgkin | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0024530 | Malaria | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0027831 | Neurofibromatosis 1 | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0032002 | Pituitary Diseases | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0036220 | Kaposi Sarcoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0039101 | synovial sarcoma | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0041341 | Tuberous Sclerosis | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0043119 | Werner Syndrome | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0078911 | AIDS-Associated Nephropathy | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C0079731 | B-Cell Lymphomas | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C3489791 | Parkinson Disease, Familial, Type 1 | 0.0005494535684262 | BEFREE |
5594 | MAPK1 | C3714948 | PACHYONYCHIA CONGENITA 3 | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C3805278 | Extrahepatic Cholangiocarcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C3811653 | Experimental Organism Basal Cell Carcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C3714636 | Pneumonitis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C3539909 | Allergic disposition | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C4048306 | Multiple endocrine neoplasia Type 2 | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C4049702 | Focal Segmental Glomerulosclerosis, Not Otherwise Specified | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C4054122 | Rat Adrenal Gland Pheochromocytoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C4082974 | Dupuytren's Disease | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0001080 | Achondroplasia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0001175 | Acquired Immunodeficiency Syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0001430 | Adenoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0001973 | Alcoholic Intoxication, Chronic | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0003175 | Anthrax disease | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0003949 | Asbestosis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0004238 | Atrial Fibrillation | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0004936 | Mental disorders | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0005411 | Biliary Atresia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0006118 | Brain Neoplasms | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0007120 | Bronchioloalveolar Adenocarcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0007130 | Mucinous Adenocarcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0007194 | Hypertrophic Cardiomyopathy | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0008073 | Developmental Disabilities | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0008487 | Chordoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0009241 | Cognition Disorders | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0011849 | Diabetes Mellitus | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0011881 | Diabetic Nephropathy | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0013312 | Dupuytren Contracture | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0013336 | Dwarfism | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0014057 | Japanese Encephalitis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0014060 | Encephalitis, St. Louis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0014335 | Enteritis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0014544 | Epilepsy | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0015230 | Exanthema | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0015625 | Fanconi Anemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0015923 | Fetal Alcohol Syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0015974 | Periodic fever | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0016037 | Fibrodysplasia Ossificans Progressiva | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0017205 | Gaucher Disease | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0017658 | Glomerulonephritis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0017661 | IGA Glomerulonephritis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0017668 | Focal glomerulosclerosis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0018133 | Graft-vs-Host Disease | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0018378 | Guillain-Barre Syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0018799 | Heart Diseases | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0018916 | Hemangioma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0018923 | Hemangiosarcoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0019100 | Severe Dengue | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0019163 | Hepatitis B | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0019207 | Hepatoma, Morris | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0019348 | Herpes Simplex Infections | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0019621 | Histiocytosis, Langerhans-Cell | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0020473 | Hyperlipidemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0021051 | Immunologic Deficiency Syndromes | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0021053 | Immune System Diseases | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0021841 | Intestinal Neoplasms | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0022680 | Polycystic Kidney Diseases | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0022716 | Menkes Kinky Hair Syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0023267 | Fibroid Tumor | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0023290 | Leishmaniasis, Visceral | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0023440 | Acute Erythroblastic Leukemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0023449 | Acute lymphocytic leukemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0023479 | Acute myelomonocytic leukemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0023480 | Leukemia, Myelomonocytic, Chronic | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0023487 | Acute Promyelocytic Leukemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0023493 | Adult T-Cell Lymphoma/Leukemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0024198 | Lyme Disease | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0024301 | Lymphoma, Follicular | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0025268 | Multiple Endocrine Neoplasia Type 2a | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0026847 | Spinal Muscular Atrophy | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0026896 | Myasthenia Gravis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0026918 | Mycobacterium Infections | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0027830 | neurofibroma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0027962 | Melanocytic nevus | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0029422 | Osteochondrodysplasias | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0029453 | Osteopenia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0029464 | Osteosclerosis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0030354 | Papilloma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0030809 | Pemphigus Vulgaris | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0031030 | Periapical Periodontitis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0031099 | Periodontitis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0031106 | Periodontitis, Juvenile | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0031117 | Peripheral Neuropathy | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0032285 | Pneumonia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0033774 | Pruritus | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0033822 | Pseudomyxoma Peritonei | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0033999 | Pterygium | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0035112 | Reoviridae Infections | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0035435 | Rheumatism | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0035869 | Rotavirus Infections | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0036472 | Scrub Typhus | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0036572 | Seizures | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0037274 | Dermatologic disorders | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0039743 | Thanatophoric Dysplasia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0041327 | Tuberculosis, Pulmonary | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0041834 | Erythema | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0042029 | Urinary tract infection | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0042133 | Uterine Fibroids | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0042900 | Vitiligo | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0043154 | Dental White Spot | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0043395 | Yellow Fever | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0079745 | Lymphoma, Large-Cell, Follicular | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0080032 | Pleural Effusion, Malignant | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0085136 | Central Nervous System Neoplasms | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0085413 | Polycystic Kidney, Autosomal Dominant | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0085669 | Acute leukemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0086132 | Depressive Symptoms | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0087012 | Ataxia, Spinocerebellar | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0149678 | Epstein-Barr Virus Infections | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0151650 | Renal fibrosis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0151779 | Cutaneous Melanoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0151908 | Dry skin | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0152018 | Esophageal carcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0153381 | Malignant neoplasm of mouth | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0155626 | Acute myocardial infarction | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0158266 | Intervertebral Disc Degeneration | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0162678 | Neurofibromatoses | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0162820 | Dermatitis, Allergic Contact | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0175695 | Sotos' syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0175704 | LEOPARD Syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0205748 | Dysplastic Nevus | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0206525 | Tuberculosis, Drug-Resistant | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0206655 | Alveolar rhabdomyosarcoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0206686 | Adrenocortical carcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0206706 | Verrucous carcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0206727 | Nerve Sheath Tumors | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0220641 | Lip and Oral Cavity Carcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0220650 | Metastatic malignant neoplasm to brain | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0221715 | CARCINOMA INTESTINAL | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0232119 | Pulsus trigeminus | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0233514 | Abnormal behavior | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0238198 | Gastrointestinal Stromal Tumors | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0238461 | Anaplastic thyroid carcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0239946 | Fibrosis, Liver | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0240066 | Iron deficiency | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0242583 | Bare Lymphocyte Syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0242596 | Neoplasm, Residual | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0243038 | Carcinoma, Lewis Lung | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0263361 | Psoriasis vulgaris | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0263630 | Hypertrophic disorder of skin, unspecified | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0265202 | Seckel syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0265252 | Coffin-Lowry syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0268251 | Gaucher Disease, Type 3 (disorder) | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0268390 | Muckle-Wells Syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0272173 | Myelokathexis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0276275 | Disease due to Parvoviridae | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0276447 | Rhinovirus infection | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0278488 | Carcinoma breast stage IV | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0278688 | Stage IV Ovarian Carcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0280100 | solid tumor | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0280222 | stage, pancreatic cancer | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0302592 | Cervix carcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0333983 | Hyperplastic Polyp | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0334579 | Anaplastic astrocytoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0334674 | Acute panmyelosis with myelofibrosis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0338656 | Impaired cognition | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0346360 | Malignant melanoma of conjunctiva | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0349639 | Juvenile Myelomonocytic Leukemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0376544 | Hematopoietic Neoplasms | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0392077 | Cardiac sarcoidosis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0398368 | Lymphatic Abnormalities | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0409818 | Chronic Infantile Neurological, Cutaneous, and Articular Syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0410528 | Skeletal dysplasia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0494165 | Secondary malignant neoplasm of liver | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0521530 | Lung consolidation | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0521585 | Gastrointestinal mucositis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0521607 | Peritoneal Fibrosis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0524851 | Neurodegenerative Disorders | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0524910 | Hepatitis C, Chronic | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0553580 | Ewings sarcoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0553665 | Skin endocrine disorder | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0553723 | Squamous cell carcinoma of skin | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0587248 | Costello syndrome (disorder) | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0677607 | Hashimoto Disease | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0677936 | Refractory cancer | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0685938 | Malignant neoplasm of gastrointestinal tract | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0729233 | Dissecting aneurysm of the thoracic aorta | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0730328 | Central Serous Chorioretinopathy | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0751674 | Lymphangioleiomyomatosis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0751690 | Malignant Peripheral Nerve Sheath Tumor | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0796004 | Kabuki make-up syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0848332 | Spots on skin | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0855082 | Hodgkin's disease refractory | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0856169 | Endothelial dysfunction | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0858252 | breast adenocarcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0920646 | Renal ischaemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0947751 | Vascular inflammations | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0948008 | Ischemic stroke | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0948192 | primary infection nos | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C0949664 | Tauopathies | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1136084 | Plasma cell dyscrasia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1153706 | Endometrial adenocarcinoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1175175 | Severe Acute Respiratory Syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1260899 | Anemia, Diamond-Blackfan | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1275081 | Cardio-facio-cutaneous syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1292769 | Precursor B-cell lymphoblastic leukemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1327920 | childhood chronic myelogenous leukemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1333064 | Classical Hodgkin's Lymphoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1334455 | Pulmonary Sclerosing Hemangioma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1334699 | Mesenchymal Cell Neoplasm | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1449563 | Cardiomyopathy, Familial Idiopathic | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1510586 | Autism Spectrum Disorders | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1510885 | Angiogenic Switch | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1512127 | HER2 gene amplification | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1512409 | Hepatocarcinogenesis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1519689 | Tumor Promotion | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1527336 | Sjogren's Syndrome | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1531553 | Dendritic cell neoplasm | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1559154 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1654637 | androgen independent prostate cancer | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1658953 | tumor vasculature | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1708565 | Invasive Skin Melanoma | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1847835 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1849452 | SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder) | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1849508 | EPILEPSY, PYRIDOXINE-DEPENDENT | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1851841 | ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1 | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1861303 | SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder) | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1862382 | SVEINSSON CHORIORETINAL ATROPHY | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1864040 | Cerebral Cavernous Malformations 3 | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1868678 | THANATOPHORIC DYSPLASIA, TYPE I (disorder) | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1956346 | Coronary Artery Disease | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C1969623 | NEUROFIBROMATOSIS, TYPE 1-LIKE SYNDROME | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C2348101 | Destructive Arthritis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C2745900 | Promyelocytic leukemia | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C2752147 | XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C2919945 | Cavernous Hemangioma of Brain | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C2931418 | Bare lymphocyte syndrome 2 | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C2938905 | Central Nervous System Sensitization | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C2985290 | Fetal Alcohol Spectrum Disorders | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C3160909 | Autoimmune arthritis | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C3203102 | Idiopathic pulmonary arterial hypertension | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C3272363 | Ischemic Cerebrovascular Accident | 0.0002747267842131 | BEFREE |
5594 | MAPK1 | C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.0002747267842131 | BEFREE |